SARS-CoV-2

An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.

In this webinar, Grégoire Lauvau and Marcus Buggert will discuss the function and role of memory T cells in health and disease.

A tornado-like vortex sampling technology detects low levels of SARS-CoV-2 viral particles within minutes.

Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.

Scientists present the latest research on infection prevention and treatment, including COVID-19 and tropical infectious diseases.

Vaccination against one SARS-CoV-2 variant can yield antibodies with efficacy against other viral variants.

A nucleic acid detection platform that marries CRISPR diagnostic tools with bioluminescence could accelerate treatment decisions in the clinic.

Ana Teresa Freitas discussed how individual variation in vitamin D synthesis and metabolism influences susceptibility to upper respiratory viruses.

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

mRNA-encoded self-assembling enveloped virus-like particles presenting SARS-CoV-2 spike protein enhance immunity and may provide better protection against viral variants. 

Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.

SARS-CoV-2 infection triggers structural changes in the host cell’s DNA, which provide a molecular explanation for long COVID, a new study suggests. 

Putting the pieces together for molecular diagnostics and infectious disease research

Scientists prepare for the future by filling in the research gaps between zoonotic viral reservoirs, emerging viruses, and human immune defenses.

Researchers dissect the Neanderthal-derived region on chromosome 3 that drives severe COVID-19 to zero in on the key causal variants.

Males recovered from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges.

By engineering structures out of DNA, scientists could potentially prevent larger viruses, like coronaviruses and influenza viruses, from interacting with cells.

Researchers employ peripheral blood mononuclear cells (PBMCs) in clinical and academic applications related to the immune system and regenerative medicine.